Laboratory Managed Serivce

Concepts

• laboratory managed service
• birmingham
• biomedical equipment
• comprehensive managed service
• laboratory equipment
• laboratory
• laboratory managed serivce
• management of any third party involvement
• service contract
• equipment installation

Location

West Midlands England:

Description

Laboratory Managed Service

Total Quantity or Scope

A Laboratory Managed Service Contract which will include equipment installation and commissioning and the supply of training, maintenance, consumables and service availability; along with the management of any third party involvement. The Supplier will provide a comprehensive managed service that will act as an enabler for the delivery of clinical services, improve outcomes and support the streamlining of clinical pathways.

Award Detail

CPV Codes

• 38434540 - Biomedical equipment
• 51430000 - Installation services of laboratory equipment

Legal Justification

University Hospitals Birmingham NHS Trust (UHB) intends to enter into a new contract with Abbott Laboratories Limited. The main benefit of entering into this contract revolves around the stability of application platforms while service consolidation takes place over the networks. As stated in the NHSE state of the nation document; “Consolidating pathology services allows for most consistent, clinically appropriate turnaround times ensuring the right test is available at the right time… consolidation can ensure an appropriate critical mass to support specialist diagnostics, so that patients have equal access to key tests and services are sustainable” As the capacity for change in the system is currently limited by post-Covid recovery plans, increased Emergency Department activity and other important projects for future productivity and performance (i.e. the current implantation of a new LIMS) a change of supplier will endanger the successful delivery of all of these important projects. Aligned to this a change of major analytical platform – however well planned – will always likely result is a reduction in productivity and consequently the restoration and recovery plan will be severely affected as will current ED turnaround times. It is assessed that the patients of Birmingham and Solihull will be put at a significant disadvantage if a fundamental piece of the diagnostic process undergoes change at this moment in time. Future projects will be enabled and better served by not embarking on a period of change, particularly with reference to a wider BSOL ICS consolidation – including Birmingham Women’s and Children’s Hospital. In addition, with the implementation of the LIMS across BSOL, in future we will have a digital environment which is standardised and working in all providers of laboratory services in Birmingham and Solihull, reducing the risks of making an analytical transition for the trusts and the suppliers.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **